Clodifen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clodifen

Quick Facts: Clodifen (Diclofenac)

Property Description
Active ingredient Diclofenac (Sodium/Potassium salt)
Form Tablets, Capsules, Solution for Injection, Gels, Suppositories
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Reduction of Pain, Inflammation, and Fever
Origin Synthetic Phenylacetic acid derivative

Clodifen: Identity and Pharmacological Classification

Clodifen is a medicinal preparation whose core component is the active ingredient Diclofenac, classifying it as a Nonsteroidal anti-inflammatory drug (NSAID). This agent is a synthetic Phenylacetic acid derivative utilized to mitigate symptoms related to inflammation and pain. Diclofenac is an analgesic and anti-inflammatory agent used across various treatment contexts, a status recognized in clinical practice for the effective reduction of generalized body discomfort and swelling.

Diclofenac is clinically recognized for its balanced potency in addressing both pain and inflammation. The compound is commonly stabilized as either the Diclofenac sodium or Diclofenac potassium salt, a formulation difference often associated with variations in the rate of drug absorption. Diclofenac has an established use for the relief of general pain and inflammatory states, where the drug’s principal utility is in reducing pain and calming inflammation.

What is the General Purpose of Diclofenac (Clodifen)?

The general purpose of Clodifen is to serve as a non-opioid analgesic by interrupting the body’s chemical cascade that generates pain and swelling. Diclofenac achieves this through its main action as a Cyclooxygenase inhibitor, which limits the synthesis of prostaglandins—the key signaling molecules responsible for driving inflammation and fever.

This fundamental action translates into the medication’s utility for diminishing different types of pain, lessening swelling, and helping to normalize elevated body temperature. The drug is a monopreparation, focusing the therapeutic outcome solely on the anti-inflammatory and pain-relieving effects of the single active ingredient. Clodifen is available in several high-level dosage forms, including tablets, capsules, injections, and topical gels, allowing for various routes of administration to achieve either systemic or localized peripheral action.

What side effects are possible with Clodifen?

Possible side effects and safety information

Clodifen (Diclofenac) is associated with official safety classifications that detail potential side effects and serious risks, primarily organized by System-Organ Class (SOC) as defined in regulatory documents.

Serious Systemic Risks

The most serious label-documented risks involve two major systemic issues. The first is an increased risk of serious Cardiovascular (CV) Thrombotic Events, including myocardial infarction and stroke, which can be fatal. This risk may increase with the duration of use and at higher doses. The second is the risk of Gastrointestinal (GI) Ulceration, Bleeding, and Perforation, which may occur without warning symptoms and is more frequent in older adults. Use is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with established congestive heart failure (NYHA Class II-IV).

Adverse Reaction Classification

Adverse reactions are classified using standard regulatory frequency terms. Common effects (ge 1/100 to <1/10) listed under Nervous System and Gastrointestinal disorders include headache, dizziness, nausea, and dyspepsia. Rare (ge 1/10,000 to <1/1,000) serious events documented under Hepatobiliary disorders include hepatitis and liver dysfunction. Very Rare effects (<1/10,000) include severe cutaneous reactions, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The use of the medicine is contraindicated during the third trimester of pregnancy due to documented fetal risk.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory documents list a range of officially documented clinical manifestations following an overdose of Clodifen (Diclofenac). Common symptoms reported in official labeling include gastrointestinal disturbances such as nausea, vomiting, and epigastric pain, along with central nervous system (CNS) effects like drowsiness, lethargy, headache, and tinnitus.

Potential for Severe Outcomes

A significant overdose may progress to severe and potentially life-threatening outcomes. Official warnings mandate attention to the risk of acute renal failure, hepatic damage (liver dysfunction), and severe gastrointestinal bleeding or perforation. In certain cases, severe CNS toxicity, including convulsions or coma, has been reported in official documentation. An increased risk of toxicity is specifically noted for patients with pre-existing renal or hepatic impairment.

Immediate Actions Required

The primary requirement mandated by government health authorities is to seek immediate medical attention if an overdose is suspected. Individuals are instructed to contact emergency services or a poison control center immediately. Regulatory guidance confirms that the management of a Clodifen overdose is exclusively symptomatic and supportive. Procedures such as gastric decontamination, including the use of activated charcoal, may be considered in a hospital setting. The official regulatory profile explicitly states that no specific antidote is known for Diclofenac toxicity.

Therapeutic Uses of Clodifen

Clodifen is considered relevant for managing symptoms associated with conditions characterized by periods of heightened symptoms, which include Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It helps address symptom clusters that may become intense or disruptive, such as symptoms related to physical discomfort, joint stiffness, and tenderness. Its application supports patients during difficult episodes by easing symptom load and contributing to overall well-being.

The medication is also relevant when supportive symptom management is appropriate, applied in clinical settings that involve acute or unstable symptom patterns. It is commonly used across conditions presenting with acute episodes that interfere with daily comfort, such as episodic manifestations like acute migraine attacks, primary dysmenorrhea (menstrual cramps), and discomfort following minor musculoskeletal injuries like sprains and strains.

It is relevant for easing symptoms related to systemic imbalance, and may be part of symptomatic management for elevated body temperature (fever) associated with inflammatory processes. By addressing these symptoms, Clodifen may assist with maintaining functional stability and supports general well-being during symptomatic phases.


Quick Fact: Therapeutic Focus: Pain, Inflammation, and Stiffness

Focus Area Symptom Domain Typical Context
Chronic Joint pain, stiffness, tenderness Symptomatic support for Arthritis (OA, RA)
Acute Severe localized pain, swelling Acute episodes including Migraine, sprains, gout
Supportive Elevated body temperature Fever associated with inflammatory states

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Population Eligibility Rules for Clodifen (Diclofenac)

Clodifen, an NSAID, is subject to strict population eligibility rules defined by government regulatory agencies. These rules govern use based on medical history, age, and organ function.

Absolute Contraindications

Use is contraindicated and explicitly prohibited in populations with:

  • A known history of hypersensitivity or allergic-type reactions, including aspirin-sensitive asthma, to Diclofenac or any other NSAID.
  • Established cardiovascular disease, including congestive heart failure (NYHA Class II–IV), ischaemic heart disease, peripheral arterial disease, or cerebrovascular disease.
  • The setting of Coronary Artery Bypass Graft (CABG) surgery.

Restricted and Conditional Use

  • Pregnancy: Use is contraindicated from the third trimester (at 30 weeks gestation and later) and avoided from 20 weeks gestation.
  • Organ Function: Use is avoided in patients with advanced renal disease and requires caution in those with hepatic impairment.
  • Pediatric Use: For many systemic formulations, safety and effectiveness are not established in children under 18 years of age.
  • Older Adults: While use is established, greater caution is mandated due to the higher documented risk of serious gastrointestinal events in this population.

What should I know about interactions with other medicines?

Clodifen Interactions with other medicines and products are officially documented across several domains to ensure appropriate co-administration rules are followed.

Co-administration is formally contraindicated in certain clinical contexts, including the treatment of pain following Coronary Artery Bypass Graft (CABG) surgery. Use is also prohibited in patients with established severe ischaemic heart disease or specific, history-documented allergic reactions to Aspirin or other NSAIDs. Ingesting Alcohol concurrently is documented to significantly increase the risk of serious gastrointestinal bleeding.

Regulatory information identifies pharmacodynamic interactions that increase risk. Combining Clodifen with Aspirin, Anticoagulants (e.g., Warfarin), or SSRIs/SNRIs raises the official risk of bleeding. Furthermore, Clodifen may officially diminish the desired effect of medicines such as ACE Inhibitors, ARBs, and Diuretics.

The product label also details pharmacokinetic interactions where drug exposure is modified. The concentration of Clodifen is officially increased when co-administered with strong metabolic inhibitors like Voriconazole. Conversely, Diclofenac can officially increase the serum concentrations of co-administered medicines, including Digoxin and Lithium.

Specific cautions exist for combinations with ACE Inhibitors/ARBs in elderly or renally impaired patients, where the risk of deterioration of renal function is heightened. Lastly, certain oral formulations have administration rules requiring separation from food to prevent a documented reduction in therapeutic effectiveness.

Mechanism of Action

How Clodifen Works: Mechanism of Action

Clodifen (diclofenac) functions primarily as a non-selective inhibitor of the cyclooxygenase (COX) enzymes, specifically targeting both the COX-1 and COX-2 isoforms. These enzymes are pivotal in the arachidonic acid cascade, catalyzing the conversion of arachidonic acid into prostanoids, which include prostaglandins and thromboxanes.

The inhibition of COX-2 reduces the synthesis of prostanoids that are typically induced during cellular stress and injury. A key consequence of this interaction is the localized reduction of prostaglandin E2 ( PGE2) concentration in peripheral tissues. Beyond the core COX pathway, Clodifen exhibits additional pharmacodynamic activities, including the modification of arachidonic acid release and uptake, and potential inhibition of lipoxygenase enzymes.

At a system level, Clodifen may influence central nervous system pathways, including the activation of the nitric oxide-cGMP pathway. It accumulates preferentially in synovial fluid, establishing a prolonged presence at the target site of the musculoskeletal system, which results in sustained local modulation of prostanoid-mediated signaling.

Dosage and Administration Information

How to Use Clodifen

Clodifen (Diclofenac) usage is governed by administration protocols that specify the route, dose, and duration. The general principle for all use is to administer the lowest effective dose for the shortest possible duration to manage symptoms.


Official Routes and Administration Principles

Route of Administration Typical Use Context
Oral (Tablets, Capsules) Systemic use for chronic or acute conditions.
Intramuscular (IM) / Intravenous (IV) Restricted short-term systemic use for acute, severe pain.
Topical (Gel, Solution) Localized use for pain and inflammation in joints.

Labeled Dosing and Scheduling

Clodifen is prescribed in several dosage forms, each with specific timing requirements. For systemic oral use, common maintenance doses for chronic conditions range from 50 mg to 75 mg, typically taken two or three times daily, with a usual maximum of 150 mg per day. Extended-release formulations are designed for once-daily administration.

Administration timing depends on the formulation: immediate-release (IR) forms are taken on an empty stomach for rapid absorption, while delayed-release (enteric-coated) tablets are typically swallowed whole with liquid and may be taken with or after food. Parenteral use (IM/IV) is restricted to a maximum course of two days.

Procedural Instructions

Delayed-release and extended-release tablets must be swallowed whole and must not be crushed, split, or chewed, as this compromises the specialized drug delivery mechanism. Injectable preparations require proper technique, such as deep intragluteal injection for IM use, and must be administered by slow infusion for IV use, not as a rapid bolus. For geriatric patients, the lowest effective dose is advised upon initiation.

Recent Clinical Evidence

Clodifen: Recent Clinical Evidence

The research base for Clodifen (Diclofenac) involves numerous clinical studies, including large-scale systematic reviews and randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time and to monitor patient-reported outcomes across various contexts of pain and inflammation. The findings describe patterns observed in these studies but research does not determine whether an individual will respond similarly.


Evidence for Symptomatic Support in Chronic Joint Conditions

Research has explored Clodifen's relevance in trials assessing symptomatic patterns in conditions such as Osteoarthritis (OA). These studies primarily focused on monitoring changes in patient-reported outcomes describing physical discomfort, stiffness, and functional imbalance over defined time intervals. Randomized Controlled Trials were applied in research contexts involving fluctuating symptoms, comparing oral and topical forms against placebo controls. Findings describe patterns observed in the alteration of pain and function scores in these study populations.


Evidence for Use in Acute, Short-Term Pain Episodes

Research has also explored Clodifen's relevance in trials assessing short-term or episodic symptom patterns, focusing on conditions associated with acute episodes, such as minor musculoskeletal injuries and post-operative pain. This research typically relies on single-dose or very short-term controlled trials. Outcomes monitored included the time it took for patients to report initial change and the overall measure of pain change over the first few hours after administration. Some studies described distinct patterns of early symptom change for formulations designed for rapid absorption.


Areas of Research Uncertainty and Study Gaps

The current research landscape notes several areas where certainty remains low or data are insufficient. Research observing responses over defined time intervals in acute pain studies has limited follow-up durations, meaning that long-term effects on healing or chronicity are not fully established. Similarly, long-term outcomes for chronic conditions beyond 12 weeks are not fully characterized. Furthermore, the evidence quality varies across studies, with heterogeneity and inconsistency noted in the results for some topical formulations, and a substantial placebo/vehicle response often reported in the control groups. Research describes that older adults were included in studies, but data for other specific comorbidity groups remain insufficient.

Key Studies & References Diclofenac (Specific Indications) - NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Clodifen (FAQ)

Q: How quickly should I expect to feel relief after taking Clodifen?

A: Studies on fast-acting formulations suggest initial change may be reported within 30 to 45 minutes. The exact time it takes for an individual to notice relief may vary based on the specific formulation of the medicine they are taking.

Q: How long does the effect of Clodifen typically last?

A: Official pharmacological information indicates that the medicine's half-life is approximately two hours. This time frame allows for common dosing intervals of every 6 to 8 hours for pain management, as the drug continues to exert its therapeutic effects.

Q: Are there any food restrictions I should follow while on Clodifen?

A: Official product information suggests taking oral forms with or after food, which may help reduce the risk of potential stomach upset. No specific food restrictions are universally mandated by regulatory labels, beyond following the instructions for administration relative to meals.

Q: Is the long-term use of Clodifen linked to any major health risks?

A: Regulatory warnings cite an increased risk of serious cardiovascular events and gastrointestinal issues (like bleeding and ulcers). These risks may increase with the duration of use and at higher doses. Official guidelines generally advise that the lowest effective dose be used for the shortest possible duration to manage symptoms.

Q: Why does Clodifen need to be handled carefully by people with heart conditions?

A: Clodifen is associated with a risk of serious cardiovascular thrombotic events (such as heart attack or stroke). For this reason, official safety information states that the medicine is contraindicated (not to be used) in patients with established serious heart conditions, including certain classes of congestive heart failure.

Q: How does Clodifen affect the liver over time?

A: Regulatory documents note that elevations of liver enzymes can occur during treatment with this medicine. Severe liver dysfunction is considered a rare adverse event, but monitoring of hepatic function may be relevant if the medication is used for a prolonged period.

Q: What are the typical maximum daily limits for Clodifen use?

A: Regulatory labeling establishes specific maximum doses for different administration routes and formulations. For most systemic oral use in adults, the official maximum daily dose is stated in the product information. Parenteral use (injections) is often restricted to a short maximum course.

Q: Does Clodifen help with period cramps?

A: Some oral formulations of the medicine are officially indicated for the management of pain associated with dysmenorrhea (painful menstruation). This aligns with the drug's general function in reducing pain and inflammation.

Q: What are the most common side effects people report when taking Clodifen?

A: According to official adverse reaction lists, common side effects, occurring in more than 1% of patients, primarily include gastrointestinal discomfort (like nausea and indigestion), headache, and dizziness.

Q: Is it normal to feel a bit dizzy after my first dose of Clodifen?

A: Dizziness is listed in regulatory information as a common adverse reaction, meaning it is one of the more frequently reported effects. As with any new medication, it is advised to note how the medicine affects you.

Q: Can Clodifen cause problems with my stomach or digestion?

A: Official warnings cite that this medicine carries risks to the gastrointestinal system. These risks include serious issues such as ulceration, bleeding, and perforation, which may occur without clear warning symptoms.

Q: Does Clodifen affect blood pressure?

A: Regulatory documents state that diclofenac can potentially lead to new or worsening hypertension (high blood pressure). Because of this risk, monitoring of blood pressure may be relevant during treatment.

Q: Why do some people say Clodifen helps with inflammation and swelling?

A: Official information indicates the medicine's main mechanism is to inhibit specific enzymes that create prostaglandins. These chemicals are the primary drivers of inflammation and swelling in the body, so blocking their production reduces these symptoms.

Q: Can people who are older safely use Clodifen for joint pain?

A: Use is established in older adults; however, official guidelines advise greater caution due to the higher documented risk of serious gastrointestinal and cardiovascular events in this population.

Q: Can Clodifen make me tired or drowsy?

A: Official regulatory documents list drowsiness and tiredness as possible adverse effects, although they are generally classified as uncommon or very rare. Patients are generally advised to determine how the medicine affects them before engaging in activities that require full alertness.

Q: Is Clodifen available over-the-counter in some countries?

A: In certain countries, some low-strength formulations, particularly topical forms like gels for localized pain, may be available for purchase without a prescription. Systemic (oral) use often requires a prescription, depending on the regulatory guidelines of the region.

Q: How long is it generally safe to take Clodifen for a chronic issue?

A: For chronic conditions, regulatory warnings indicate that the risk of serious side effects may increase with both the dose and the duration of treatment. The use of this medicine is generally recommended to be at the lowest effective dose for the shortest time possible.

Q: Can Clodifen be used for pain from a dental procedure?

A: Yes, some formulations of this medicine are officially indicated for the short-term treatment of post-operative pain and swelling, including pain that follows dental surgery or other minor procedures.

Q: How does Clodifen compare to other similar drugs in terms of half-life?

A: The terminal half-life of the unchanged medicine in the body is approximately two hours. The half-life is a pharmacological measure that indicates the speed at which the medicine is processed and eliminated from the bloodstream.

Q: What's the reason for the age restriction on Clodifen in some places?

A: For many systemic (oral) forms, regulatory agencies have determined that the safety and effectiveness have not been established in children under 18 years of age. This often results in restrictions or contraindications for use in pediatric populations.

Q: Does Clodifen have a known interaction with alcohol?

A: Official regulatory warnings advise that consuming alcohol while taking this medicine is associated with a significantly increased risk of serious gastrointestinal bleeding. The concurrent use of alcohol and Clodifen should be avoided.

Q: Will Clodifen show up on a standard drug test?

A: No, as a Nonsteroidal Anti-inflammatory Drug (NSAID), this medicine is not classified as a controlled substance. Therefore, it is generally not included in the screening panels of standard drug tests.

Q: Is it true that Clodifen comes in different forms like tablets and gels?

A: Yes, official regulatory documents list a variety of dosage forms for this medicine. These include oral products like tablets and capsules, as well as forms for external (topical) use, such as gels and solutions.

Q: What are the inactive ingredients in a typical Clodifen tablet?

A: Official labeling lists all components of the drug. Inactive ingredients typically include various excipients such as binders, fillers, stabilizers, and coating materials (e.g., iron oxide, talc, titanium dioxide) that help form the tablet but do not have a therapeutic effect.

Q: Is Clodifen mainly used for acute or chronic pain?

A: The medicine has regulatory indications for both: it is used for the short-term treatment of acute pain (such as a muscle injury) and for the management of signs and symptoms of chronic conditions (such as certain types of arthritis).

Q: Does taking Clodifen affect my ability to drive or operate machinery?

A: Because some individuals may experience side effects like dizziness or drowsiness, patients are advised to determine how the medicine affects them before engaging in activities that require full alertness.

Q: Is there a generic version of Clodifen available?

A: As the active ingredient is Diclofenac, regulatory agencies have approved multiple generic versions of various formulations. This means that non-branded, equivalent versions of the medicine are widely available.

Q: Is Clodifen known to cause water retention or swelling?

A: Official product information reports that fluid retention and edema (swelling) have been associated with the use of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including Clodifen.

How should Clodifen be stored and disposed of?

How to Store and Dispose of Diclofenac (Clodifen)

The storage and disposal of diclofenac are governed by regulatory instructions to ensure product stability and safety. These requirements are specific to the formulation (e.g., tablet, gel).


Official Storage Conditions

Requirement Constraint
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not store above 30 C.
Protection Protect from light and moisture; specific formulations must not be frozen.
Container Keep the medicine in its original container and ensure it is kept tightly closed.
Child Safety Must be stored out of the sight and reach of children.

Disposal

Any unused or expired diclofenac product must be disposed of in accordance with local regulations. Official guidelines often advise against discarding the product in wastewater. If local take-back programs are unavailable, some non-flush medicines may be mixed with an undesirable substance, placed in a sealed bag, and discarded in the household trash, after removing personal information from packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clodifen found in:

A-Z Index: